Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 165

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Mechanistic Target of Rapamycin Complex 1 Expands Th17 and IL-4+ CD4−CD8− Double-Negative T Cells and Contracts Regulatory T Cells in Systemic Lupus Erythematosus

Open access
Kato, Hiroshi, Perl, Andras · 2014 · The Journal of Immunology

Abstract

The mechanistic target of rapamycin (mTOR) is activated in CD4−CD8− double-negative (DN) T cells and its blockade is therapeutic in systemic lupus erythematosus (SLE) patients. Murine studies showed the involvement of mTOR complex 1 (mTORC1) and 2 (mTORC2) in the differentiation of Th1/Th17 cells and Th2 cells, respectively. In this study, we investigated the roles of mTORC1 and mTORC2 in T cell lineage development in SLE and matched healthy control (HC) subjects. mTORC1 activity was increased, whereas mTORC2 was reduced, as assessed by phosphorylation of their substrates phosphorylated S6 kinase 1 or phosphorylated S6 ribosomal protein and phosphorylated Akt, respectively. Rapamycin inhibited mTORC1 and enhanced mTORC2. IL-4 expression was increased in freshly isolated CD8+ lupus T cells (SLE: 8.09 ± 1.93%, HC: 3.61 ± 0.49%; p = 0.01). DN T cells had greater IL-4 expression than CD4+ or CD8+ T cells of SLE patients after 3-d in vitro stimulation, which was suppressed by rapamycin (control: 9.26 ± 1.48%, rapamycin: 5.03 ± 0.66%; p < 0.001). GATA-3 expression was increased in CD8+ lupus T cells (p < 0.01) and was insensitive to rapamycin treatment. IFN-γ expression was reduced in all lupus T cell subsets (p = 1.0 × 10−5) and also resisted rapamycin. IL-17 expression was increased in CD4+ lupus T cells (SLE: 3.62 ± 0.66%, HC: 2.29 ± 0.27%; p = 0.019), which was suppressed by rapamycin (control: 3.91 ± 0.79%, rapamycin: 2.22 ± 0.60%; p < 0.001). Frequency of regulatory T cells (Tregs) was reduced in SLE (SLE: 1.83 ± 0.25%, HC: 2.97 ± 0.27%; p = 0.0012). Rapamycin inhibited mTORC1 in Tregs and promoted their expansion. Neutralization of IL-17, but not IL-4, also expanded Tregs in SLE and HC subjects. These results indicate that mTORC1 expands IL-4+ DN T and Th17 cells, and contracts Tregs in SLE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.1301859

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 66

  1. Shivakumar, 1989, T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis, J. Immunol., 143, 103, 10.4049/jimmunol.143.1.103 · DOI · Paper page
  2. Takeuchi, 1984, Cellular mechanism of DNA-specific antibody synthesis by lymphocytes from systemic lupus erythematosus patients, Arthritis Rheum., 27, 766, 10.1002/art.1780270707 · doi:10.1002/art.1780270707
  3. Sieling, 2000, Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c, J. Immunol., 165, 5338, 10.4049/jimmunol.165.9.5338 · DOI
  4. Anand, 2002, Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers, Lupus, 11, 493, 10.1191/0961203302lu235oa · DOI
  5. Rajagopalan, 1990, Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4-8- T helper cell lines that express the gamma delta T-cell antigen receptor, Proc. Natl. Acad. Sci. USA, 87, 7020, 10.1073/pnas.87.18.7020 · doi:10.1073/pnas.87.18.7020
  6. Crispín, 2008, Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys, J. Immunol., 181, 8761, 10.4049/jimmunol.181.12.8761 · DOI · Paper page
  7. Amel-Kashipaz, 2001, Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus, J. Autoimmun., 17, 155, 10.1006/jaut.2001.0525 · DOI
  8. Horwitz, 1998, Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus, Arthritis Rheum., 41, 838, 10.1002/1529-0131(199805)41:5<838::AID-ART10>3.0.CO;2-S · DOI
  9. Akahoshi, 1999, Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus, Arthritis Rheum., 42, 1644, 10.1002/1529-0131(199908)42:8<1644::AID-ANR12>3.0.CO;2-L · DOI · Paper page
  10. Tucci, 2008, Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis, Clin. Exp. Immunol., 154, 247, 10.1111/j.1365-2249.2008.03758.x · DOI
  11. Min, 2001, Decreased production of interleukin-12 and interferon-gamma is associated with renal involvement in systemic lupus erythematosus, Scand. J. Rheumatol., 30, 159, 10.1080/030097401300162932 · doi:10.1080/030097401300162932
  12. Tanaka, 1999, Association of the interferon-gamma receptor variant (Val14Met) with systemic lupus erythematosus, Immunogenetics, 49, 266, 10.1007/s002510050492 · doi:10.1007/s002510050492
  13. Shah, 2010, Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus, Arthritis Res. Ther., 12, R53, 10.1186/ar2964 · DOI · Paper page
  14. Yang, 2009, Th17 and natural Treg cell population dynamics in systemic lupus erythematosus, Arthritis Rheum., 60, 1472, 10.1002/art.24499 · DOI · Paper page
  15. Wong, 2008, Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity, Clin. Immunol., 127, 385, 10.1016/j.clim.2008.01.019 · DOI · Paper page
  16. Mok, 2010, The relation of interleukin 17 (IL-17) and IL-23 to Th1/Th2 cytokines and disease activity in systemic lupus erythematosus, J. Rheumatol., 37, 2046, 10.3899/jrheum.100293 · DOI
  17. Doreau, 2009, Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus, Nat. Immunol., 10, 778, 10.1038/ni.1741 · DOI · Paper page
  18. Crispin, 2003, Quantification of regulatory T cells in patients with systemic lupus erythematosus, J. Autoimmun., 21, 273, 10.1016/S0896-8411(03)00121-5 · DOI · Paper page
  19. Liu, 2004, Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus, Scand. J. Immunol., 59, 198, 10.1111/j.0300-9475.2004.01370.x · DOI · Paper page
  20. Miyara, 2005, Global natural regulatory T cell depletion in active systemic lupus erythematosus, J. Immunol., 175, 8392, 10.4049/jimmunol.175.12.8392 · DOI · Paper page
  21. Mellor-Pita, 2006, Decrease of regulatory T cells in patients with systemic lupus erythematosus, Ann. Rheum. Dis., 65, 553, 10.1136/ard.2005.044974 · DOI
  22. Bonelli, 2008, Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE), Int. Immunol., 20, 861, 10.1093/intimm/dxn044 · DOI · Paper page
  23. Lee, 2008, Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus, Rheumatology (Oxford), 47, 789, 10.1093/rheumatology/ken108 · DOI
  24. Alvarado-Sánchez, 2006, Regulatory T cells in patients with systemic lupus erythematosus, J. Autoimmun., 27, 110, 10.1016/j.jaut.2006.06.005 · DOI · Paper page
  25. Zhang, 2008, Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus, Ann. Rheum. Dis., 67, 1037, 10.1136/ard.2007.083543 · DOI
  26. Suárez, 2006, Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids, Ann. Rheum. Dis., 65, 1512, 10.1136/ard.2005.049924 · DOI
  27. Yan, 2008, Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells, Arthritis Rheum., 58, 801, 10.1002/art.23268 · DOI · Paper page
  28. Valencia, 2007, Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus, J. Immunol., 178, 2579, 10.4049/jimmunol.178.4.2579 · DOI · Paper page
  29. Vargas-Rojas, 2008, Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance, Lupus, 17, 289, 10.1177/0961203307088307 · DOI
  30. Yates, 2008, Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis, Clin. Exp. Immunol., 153, 44, 10.1111/j.1365-2249.2008.03665.x · DOI
  31. Li, 2011, A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity, Immunity, 34, 541, 10.1016/j.immuni.2011.04.006 · DOI · Paper page
  32. Jones, 2007, Revving the engine: signal transduction fuels T cell activation, Immunity, 27, 173, 10.1016/j.immuni.2007.07.008 · DOI · Paper page
  33. Fox, 2005, Fuel feeds function: energy metabolism and the T-cell response, Nat. Rev. Immunol., 5, 844, 10.1038/nri1710 · DOI · Paper page
  34. Powell, 2010, The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism, Immunity, 33, 301, 10.1016/j.immuni.2010.09.002 · DOI · Paper page
  35. Delgoffe, 2011, The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2, Nat. Immunol., 12, 295, 10.1038/ni.2005 · DOI · Paper page
  36. Delgoffe, 2009, The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment, Immunity, 30, 832, 10.1016/j.immuni.2009.04.014 · DOI · Paper page
  37. Battaglia, 2005, Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells, Blood, 105, 4743, 10.1182/blood-2004-10-3932 · DOI · Paper page
  38. Kopf, 2007, Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells, Int. Immunopharmacol., 7, 1819, 10.1016/j.intimp.2007.08.027 · DOI · Paper page
  39. Battaglia, 2006, Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients, J. Immunol., 177, 8338, 10.4049/jimmunol.177.12.8338 · DOI · Paper page
  40. Kang, 2008, De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR, J. Leukoc. Biol., 83, 1230, 10.1189/jlb.1207851 · DOI
  41. Fernandez, 2009, Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation, J. Immunol., 182, 2063, 10.4049/jimmunol.0803600 · DOI · Paper page
  42. Fernandez, 2006, Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus, Arthritis Rheum., 54, 2983, 10.1002/art.22085 · DOI · Paper page
  43. Tan, 1982, The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum., 25, 1271, 10.1002/art.1780251101 · DOI · Paper page
  44. Bombardier, 1992, Derivation of the SLEDAI. A disease activity index for lupus patients, Arthritis Rheum., 35, 630, 10.1002/art.1780350606 · DOI · Paper page
  45. Richie, 1988, Altered expression of lymphocyte differentiation antigens on phorbol ester-activated CD4+8+ T cells, J. Immunol., 140, 4115, 10.4049/jimmunol.140.12.4115 · doi:10.4049/jimmunol.140.12.4115
  46. Erard, 1993, Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells, Science, 260, 1802, 10.1126/science.8511588 · DOI · Paper page
  47. Crispín, 2009, Human TCR-alpha beta+ CD4- CD8- T cells can derive from CD8+ T cells and display an inflammatory effector phenotype, J. Immunol., 183, 4675, 10.4049/jimmunol.0901533 · DOI · Paper page
  48. Lai, 2013, Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus, J. Immunol., 191, 2236, 10.4049/jimmunol.1301005 · DOI
  49. Zhu, 2004, Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses, Nat. Immunol., 5, 1157, 10.1038/ni1128 · DOI · Paper page
  50. Wang, 2013, GATA-3 controls the maintenance and proliferation of T cells downstream of TCR and cytokine signaling, Nat. Immunol., 14, 714, 10.1038/ni.2623 · DOI
  51. Medsger, 2011, GATA-3 up-regulation in CD8+ T cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production, Arthritis Rheum., 63, 1738, 10.1002/art.30489 · DOI
  52. Yang, 2006, TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity, Proc. Natl. Acad. Sci. USA, 103, 6811, 10.1073/pnas.0602282103 · DOI · Paper page
  53. Sarbassov, 2004, Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton, Curr. Biol., 14, 1296, 10.1016/j.cub.2004.06.054 · DOI · Paper page
  54. Alexander, 2013, Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus, Ann. Rheum. Dis., 72, 1549, 10.1136/annrheumdis-2012-202216 · DOI
  55. Golding, 2013, The percentage of FoxP3+Helios+ Treg cells correlates positively with disease activity in systemic lupus erythematosus, Arthritis Rheum., 65, 2898, 10.1002/art.38119 · DOI
  56. Cepika, 2007, Effect of steroids on the frequency of regulatory T cells and expression of FOXP3 in a patient with systemic lupus erythematosus: a two-year follow-up, Lupus, 16, 374, 10.1177/0961203307077990 · doi:10.1177/0961203307077990
  57. Zhang, 2008, Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells, Nat. Immunol., 9, 1297, 10.1038/ni.1663 · DOI · Paper page
  58. Zhou, 2008, TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function, Nature, 453, 236, 10.1038/nature06878 · DOI · Paper page
  59. Fletcher, 2009, CD39+Foxp3+ regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis, J. Immunol., 183, 7602, 10.4049/jimmunol.0901881 · DOI · Paper page
  60. Chen, 2011, Foxp3(+) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2, Immunity, 34, 409, 10.1016/j.immuni.2011.02.011 · DOI · Paper page
  61. Pandiyan, 2011, CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model, Immunity, 34, 422, 10.1016/j.immuni.2011.03.002 · DOI · Paper page
  62. Longhi, 2012, Inhibition of interleukin-17 promotes differentiation of CD25(-) cells into stable T regulatory cells in patients with autoimmune hepatitis, Gastroenterology, 142, 1526, 10.1053/j.gastro.2012.02.041 · DOI
  63. Itoh, 2011, Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion, Circulation, 124, S187
  64. Mantel, 2007, GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells, PLoS Biol., 5, e329, 10.1371/journal.pbio.0050329 · DOI · Paper page
  65. Zeng, 2013, mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function, Nature, 499, 485, 10.1038/nature12297 · DOI · Paper page
  66. Yurchenko, 2012, Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo, PLoS ONE, 7, e35572, 10.1371/journal.pone.0035572 · DOI

Cited by

See all 165

Metadata

Authors
Kato, H., & Perl, A.
Venue
The Journal of Immunology
Published
2014-05-01
Volume
192
Issue
9
Pages
4134-4144
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2097892535
Cited by
165
References
9
FWCI
10.63
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanistic Target of Rapamycin Complex 1 Expands Th17 and IL-4+ CD4−CD8− Double-Negative T Cells and Contracts Regulatory T Cells in Systemic Lupus Erythematosus. https://app.cochat.ai/papers/10.4049/jimmunol.1301859
The paper
Kato, H., & Perl, A. (2014). Mechanistic Target of Rapamycin Complex 1 Expands Th17 and IL-4+ CD4−CD8− Double-Negative T Cells and Contracts Regulatory T Cells in Systemic Lupus Erythematosus. The Journal of Immunology. https://doi.org/10.4049/jimmunol.1301859

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.